DOSSIER · UPDATED 18 NOV 2025

Quince Therapeutics

Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the site of bone diseases…

www.quincetx.com ↗Claim this profile

Founded: 2012
Headcount: 36
Open roles: 0
Last raised: Post Ipo Equity · $22M

SECTION I · THE BRIEF

Inside Quince Therapeutics

Brief #18112Updated 18 NOV 2025SOUTH SAN FRANCISCOSEQUOIA CAPITALPOST IPO EQUITY

Employbl Dossier

Quince Therapeutics

Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the…

Founded: 2012
Headcount: 36
Open roles: 0
Last raised: Post Ipo Equity · $22M

Section II · Premium ProfileMembers only

01Engineering interview process at Quince TherapeuticsLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Quince Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Stephen Dominy

Brendan Hannah

Casey Lynch

Kristen Gafric

OPEN ROLES

Hiring at Quince Therapeutics

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $247,000,000

Quince Therapeutics' Investors

Sequoia Capital

Quince Therapeutics Funding Rounds

Post Ipo Equity
$22,000,000
Jun 12, 2025
Post Ipo Equity
$22,000,000
Jun 11, 2025
Post Ipo Equity Investors
Nantahala Capital Management
ADAR1 Capital Management
Post Ipo Equity
$125,000,000
Dec 13, 2019
Post Ipo Equity
$125,000,000
Dec 12, 2019
Post Ipo Equity Investors
KG Investments
IPO
Unknown
Jan 1, 2019
Series B
$76,000,000
May 31, 2018
Series B
$76,000,000
May 30, 2018
Series B Investors
Sequoia Capital
Pfizer Venture Investments
Verily
Lamond Family
Dolby Family Ventures
Huizenga Capital Management
Breakout Ventures
Takeda Ventures
Vulcan Capital
EPIQ Capital Group
Smallcap World Fund
RS Investments
Debt Financing
$8,000,000
Apr 14, 2017
Debt Financing
$8,000,000
Apr 13, 2017
Debt Financing Investors
Breakout Ventures
Takeda Ventures
Pfizer
Dolby Family Ventures
Lamond Family
Series A
$15,000,000
Jan 6, 2016
Series A
$15,000,000
Jan 5, 2016
Series A Investors
Pfizer
Takeda Ventures
Dolby Family Ventures
Seed
$1,000,000
Oct 6, 2014
Seed
$1,000,000
Oct 5, 2014
Seed Investors
Dolby Family Ventures

Funding info provided by Diffbot.

TAGS

Categorized in

Company Collections

These are collections Quince Therapeutics is a part of. Click on the collection name to view similar companies.

Quince Therapeutics' Investors

Sequoia Capital

Quince Therapeutics' Industries

Medical Organizations

Health Care Companies

Biotechnology Companies

LOCATIONS

Where they work

Quince Therapeutics Headquarters Location

611 Gateway Blvd. Suite 273, South San Francisco, CA, 94080

Loading map…